C 021 dihydrochloride
Chemical Name: 2-[1,4'-Bipiperidin]-1'-yl-N-cycloheptyl-6,7-dimethoxy-4-quinazolinamine dihydrochloride
Biological ActivityPotent CCR4 chemokine receptor antagonist (IC50 values are 0.14 and 0.039 μM for inhibition of chemotaxis in human and mouse respectively).
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Potent and orally bioavailable CCR4 antagonists: synthesis and structure-activity relationship study of 2-aminoquinazolines.
Yokoyama et al.
Citations for C 021 dihydrochloride
The citations listed below are publications that use Tocris products. Selected citations for C 021 dihydrochloride include:
5 Citations: Showing 1 - 5
CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection.
Authors: Palchevskiy Et al.
JCI Insight 2019;5
CCL17/TARC and CCR4 expression in Merkel cell carcinoma.
Authors: Rasheed Et al.
Circadian Expression of Migratory Factors Establishes Lineage-Specific Signatures that Guide the Homing of Leukocyte Subsets to Tissues.
Authors: He Et al.
CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury.
Authors: Kwon Et al.
J Neurosci 2015;35:15934
Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline.
Authors: McMillin Et al.
J Neuroinflammation 2014;11:121
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
VersaClone cDNA Plasmids
Reviews for C 021 dihydrochloride
Average Rating: 1 (Based on 1 Review)
Have you used C 021 dihydrochloride?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
I used it both in vivo and in vitro. In vitro, I was unable to find any impact in chemotaxis towards CCL17